Vemurafenib Drug Interactions

Brand name
  • Zelboraf
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated Details about this page

About Vemurafenib

Vemurafenib is used to treat certain types of melanoma (a type of skin cancer) that cannot be treated with surgery or that has spread to other parts of the body. It is also used to treat a certain type of Erdheim-Chester disease (ECD; a disease that causes an overproduction of a type of white blood cells).

Read the full Vemurafenib drug information page 

The Bottom Line on Vemurafenib

Supplements, herbs and foods are part of the picture here: about 170 have a rated interaction with vemurafenib, and 8 of those are rated major, so they deserve the same attention as your other medicines.

Vemurafenib is a targeted treatment for certain skin cancers, melanoma that has spread or can't be removed by surgery, and for a rare blood cell disorder called Erdheim-Chester disease. It has more documented interactions than almost any other medicine, and most are serious. Heart effects come up most, such as ondansetron for nausea and hydroxyzine for itching or anxiety, both rated major for added strain on the heart's rhythm. Before you add anything new, check it against vemurafenib with the search on this page, and ask a pharmacist about anything it turns up.

From the HelloPharmacist Editorial Team Written with AI from this page's interaction records · How we build these pages · How we use AI · Our editorial policy

Check Vemurafenib Against Another Drug or Supplement

Type a drug, a brand name or a supplement. We check it against every documented vemurafenib interaction, supplements and herbs included.

    What Could Happen When Vemurafenib Interacts

    What the 421 documented vemurafenib interaction records say could happen, grouped by the problem each one names. Tap a bar to see those drugs.

    This chart covers drug interactions only. Interactions with supplements and herbs are studied far less, so they are not counted here; they have their own section below. One interaction can name more than one problem, so the numbers add up to more than 421.

    Vemurafenib Interactions by Severity

    Contraindicated

    Vemurafenib With Supplements and Herbs

    Supplements can interact with vemurafenib too. The Natural Medicines database, which we license, rates 170 of them for an interaction with vemurafenib, and every one of the 1,327 supplements and herbs we cover has a page on taking it with vemurafenib.

    Rated for an Interaction With Vemurafenib

    Every Supplement and Herb With Vemurafenib, A to Z1,327 pages

    Each one opens its page on taking it with vemurafenib, whether or not an interaction is rated.

    Browse every supplement and herb 

    Check a supplement bottle against vemurafenib with our drug–supplement interaction checker, or scan its label.

    How Drug Interactions Work New to drug interactions? Six short figures, about a minute, show what can happen when Vemurafenib meets another medicine: a level that rises or falls, or effects that add up. See how it works 

    Look Up Another Drug

    Still Have Questions About Vemurafenib?

    Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

    About This Library

    Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

    What Each Rating Means

    Severity Levels

    • Contraindicated These should generally not be used together.
    • Major Potentially serious — often needs a change or close monitoring.
    • Moderate Can be significant — usually manageable with monitoring.
    • Minor Usually limited clinical impact.
    Back to the answer

    The References Behind Vemurafenib’s Interactions

    The 283 sources our vemurafenib interaction records cite: clinical studies, case reports and FDA prescribing information. Each pair's page lists the ones it rests on, numbered in its text, and a source link is one we checked against PubMed or Crossref. How we check them →

    1. Tiacci E, Park JH, De Carolis L, et al: Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia. N Engl J Med 2015; 373(18):1733-1747.
    2. Parry-Jones N, Joshi A, Forconi F, et al: Guideline for diagnosis and management of hairy cell leukaemia (HCL) and hairy cell variant (HCL-V). Br J Haematol 2020; 191(5):730-737. DOI 
    3. Tiacci E, De Carolis L, Simonetti E, et al: Vemurafenib plus rituximab in refractory or relapsed hairy-cell leukemia. N Engl J Med 2021; 384(19):1810-1823. DOI 
    4. Product Information: ZELBORAF(R) oral tablets, vemurafenib oral tablets. Genentech USA, Inc (per FDA), South San Francisco, CA, 2017. DailyMed 
    5. Diamond EL, Subbiah V, Lockhart AC, et al: Vemurafenib for BRAF V600-mutant Erdheim-Chester disease and Langerhans cell histiocytosis: analysis of data from the histology-independent, phase 2, open-label VE-BASKET study. JAMA Oncol 2018; 4(3):384-388.
    6. Maio M, Lewis K, Demidov L, et al: Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. Lancet Oncol 2018; 19(4):510-520.
    7. Product Information: ZELBORAF(R) oral tablets, vemurafenib oral tablets. Genentech USA, Inc. (per FDA), South San Francisco, CA, 2014. DailyMed 
    8. Product Information: ZELBORAF(R) oral tablets, vemurafenib oral tablets. Genentech USA, Inc. (per FDA), South San Francisco, CA, 2016. DailyMed 
    9. Chapman PB, Hauschild A, Robert C, et al: Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 364(26):2507-2516. PubMed 
    10. Sosman JA, Kim KB, Schuchter L, et al: Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N Engl J Med 2012; 366(8):707-714. PubMed 

    Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.